Eterna Therapeutics
ERNA
#10593
Rank
ยฃ5.24 M
Marketcap
ยฃ4.50
Share price
-1.15%
Change (1 day)
152.78%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -ยฃ57.40

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ57.23. In 2022 the company made an earnings per share (EPS) of -ยฃ93.89 an increase over its 2021 EPS that were of -ยฃ620.27.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ57.40
2022-ยฃ93.89-84.86%
2021-ยฃ620.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
ยฃ1.91-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-ยฃ1.59-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-ยฃ1.51-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-ยฃ0.09698-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
ยฃ1.02-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
ยฃ0.53-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA